Abstract:Objective To observe the effect of recombinant human endostatin (endostar) in combination with radiation on hepatic carcinoma xenografts in mice under different timing of administration, endostar dose and radiation dose.Methods (1) The xenotransplanted tumor model of human hepatic carcinoma in mice was established.The mice were randomly grouped based on timing of administration, endostar dose and radiation dose, with 10 mice in each group.The length and diameter of xenografts were measured every other day.The tumor suppress effect was compared between early administration and late administration manners.(2) The mice were divided into 6 groups with 30 mice in each group and treated in early administration manner.Then the overall survival was observed.(3) MTT assay was used to observe the synergistic effect influenced by the dose of endostar and radiation.(4) Western blotting was used to detect the expression of epidermal growth factor (EGF) and vascular endothelial growth factor receptor-1(Flt-1) in early and late administration manners.(5) Immunochemistry was used to test the expression of vascular endothelial growth factor (VEGF) and KDR, as well as microvascular density of hepatic carcinoma xenografts.(6) Cyto-apoptosis was observed by electron microscope and cell cycles and apoptotic rates were determined by flow cytometry.Results Compared with control group, endostar could suppress the growth of hepatic carcinoma xenografts (P<0.05), and early administration manner performed better than late administration manner (P<0.05).Synergistic effect was found in 8 mg/kg endostar+RT group of early administration manner, and the tumor suppress rate was 58.0%, better than other groups (P<0.05).The median overall survival of 8 mg/kg endostar+RT group was 55.6 days with the life prolonging rate of 29.3%, better than other groups (P<0.05).5 μg/ml endostar in combination with 4Gy radiation on HUVECs cells showed synergistic effect with the proliferative inhibition rate of 59.20%, better than other doses of endostar (P<0.05).200 μg/ml endostar in combination with 4 Gy radiation on HepG2 cells showed synergistic effect with the proliferative inhibition rate of 43.45%, better than other doses of endostar (P<0.05).5 μg/ml endostar in combination with different doses of radiation on HUVECs, as well as 200 μg/ml endostar in combination with different doses of radiation on HepG2 cells both showed better proliferative inhibition rates than using endostar or radiation alone (P<0.05).Western blotting test showed that the expressions of EGF in 8 mg/kg endostar group and 8 mg/kg endostar+RT group of early administration manner was lower than those of late administration manner.However, the expression of Flt-1 between the two manners had no difference (P>0.05).Endostar in combination with radiation could significantly decrease MVD of hepatic carcinoma xenografts, the MVD in 8 mg/kg endostar+RT group was 8.6±1.3, lower than other groups (P<0.05).In 8 mg/kg endostar+RT group, the expression of VEGF and KDR was lower than other groups (P<0.05).Apoptoic changes were observed under lectron microscope in endostar in combination with radiation groups.Flow cytometry showed that cell cycles were blocked in S phase in 8 mg/kg endostar+RT group, and the cyto-apoptotic rate was higher than other groups (P<0.05).Conclusion The synergistic effect of endostar in combination with radiation is correlated to timing of administration, endostar dose and radiation dose, and the effect of early administration of endostar is superior to the late.

Synergistic Inhibitory Effects of Endostatin and Radiation Therapy on Angiogenesis of Lewis Lung Cancer in Nude Mice

An Experimental Research into Endostatin Microbubble Combined with Focused Ultrasound for Anti-Tumor Angiogenesis in Colon Cancer

Anti-tumor Efficacy of Ultrasonic Cavitation is Potentiated by Concurrent Delivery of Anti-Angiogenic Drug in Colon Cancer

Anti-tumor Effect of Pegr-1-endostatin-tnf-α Recombinant Plasmid Expression Induced by Ionizing Radiation

Sensitization Effect of Endostatin for 125Ⅰ Brachytherapy on Transplanted Tumor in Nude Mice

The dose and time factors on synergistic effects of the combination of endostar and radiation against hepatic carcinoma xenografts in mice

Changes And Significance Of Lymphocyte Subsets In Patients With Advanced Nsclc Before And After Endostar Combined Chemotherapy

Therapeutic Efficacy of Recombinant Human Endostatin Combined with Chemotherapeutics in Mice-Transplanted Tumors

Endostatin Interventional Effect on Colorectal Cancer Liver Metastasis

Endostar, A Recombined Humanized Endostatin, Enhances The Radioresponse For Human Nasopharyngeal Carcinoma And Human Lung Adenocarcinoma Xenografts In Mice

[Biological Effect of Endostatin on Transplanted Human Lung Adenocarcinoma Calu-6 Tumor in Nude Mice].

Effect of radiation combined with p53 gene therapy and endostatin on mouse prostate cancer

Anticancer Treatment of Endostatin Gene Therapy by Targeting Tumor Neovasculature in C57/BL Mice.

Antiangiogenic effect of Endostar combined with Avastin:a dynamic contrast-enhanced magnetic resonance imaging study

Mechanism of Radiosensitizing Effects of Endostatin on H-520 Human Lung Squamous Cancer Cells

Process in the Mechanisms of Endostatin Combined with Radiotherapy

[Serum Levels of Endostatin and VEGF in Non-Small Cell Lung Cancer Patients and the Relationship with the Clinical Pathophysiological Characteristics].

Enhanced Anti-Tumor and Anti-Angiogenic Effects of Metronomic Cyclophosphamide Combined with Endostar in a Xenograft Model of Human Lung Cancer

Radiosensitization of Recombinant Human Endostatin in Human Lung Squamous Cancer Cells in Vitro

Anti-Tumor Effect Of Human Endostatin Mediated By Retroviral Gene Transfer In Nude Mice

Sustained delivery of endostatin improves the efficacy of therapy in Lewis lung cancer model